Training_Data_English_ja_en  

Documents (421) JSON TSV

source DB source ID text size updated at # proj. # Ann. updated_at
PubMed 7010880 [Cellular heterogeneity of steroid reactivity in human endometrial carcinoma: an approach by an immunofluorescent steroid-antibody technique (author's transl)]. The dispersed cancer cells obtained fro 1.48 KB 2015-12-07 2 0
-
PubMed 182567 [Effect of cyclic AMP and Ca++ on steroidogenesis by rat adrenal mitochondrial fraction. Studies on the mechanism of ACTH action (I) (author's transl)]. Despite the accumulation of a number of studies 2.67 KB 2015-12-07 2 0
-
PubMed 21628852 [Successful bosentan therapy in a case of pulmonary arterial hypertention developed during immunosuppressive therapy for lupus nephritis]. We report a 43-year-old female who developed pulmonary arteri 1.42 KB 2016-01-06 10 0
-
PubMed 21628853 [Case of systemic-onset juvenile idiopathic arthritis complicated with sepsis --usefulness of cytokine profile for the differentiation between macrophage activation syndrome and sepsis]. The different 1011 Bytes 2016-01-07 11 0
-
PubMed 21628847 [Basophils in skin inflammation]. Basophils represent less than 1% of peripheral blood leukocytes. Under physiological conditions, basophils principally circulate in peripheral blood, while mast cells 1.39 KB 2016-01-09 3 0
-
PubMed 23994801 Hemophagocyctic lymphohistiocytosis developed in a Japanese boy with Chédiak-Higashi syndrome. Chédiak-Higashi syndrome (CHS) is one of the primary immunodeficiency syndromes accompanied by oculocutan 1.09 KB 2016-01-11 6 0
-
PubMed 23994797 Syk inhibitors. Non-receptor type of protein-tyrosine kinase Syk (spleen tyrosine kinase) was isolated in University of Fukui in 1991. Syk is most highly expressed by haemopoietic cells and known to p 1.23 KB 2016-01-11 2 0
-
PubMed 23994800 Efficacy of high-dose intravenous immunoglobulin therapy for peripheral neuropathy in the remission stage of eosinophilic granulomatosis with polyangiitis (EGPA, Churg-Strauss syndrome). BACKGROUND: M 1.57 KB 2016-01-12 3 0
-
PubMed 23994798 The IL-23/IL-17 axis as a therapeutic target. T helper (Th) cells are known to differentiate into several distinct subsets depending on their environment. The Interleukin 17 (IL-17)-producing subset T 1.06 KB 2016-01-12 4 0
-
PubMed 23994799 Anti-RANKL antibody was approved for the treatment of osteoporosis in Japan. Fifteen years have passed since discovery of RANKL (receptor activator of NF-κB ligand), resulting in identification of the 1.16 KB 2016-01-12 3 0
-